2/5
08:30 am
hscs
University of West England Adopts HeartSciences’ MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference Center
Medium
Report
University of West England Adopts HeartSciences’ MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference Center
1/29
08:30 am
hscs
Cibolo Health Designates HeartSciences’ MyoVista Insights™ as Endorsed ECG Management Platform for Network of 123 Independent Hospitals
Medium
Report
Cibolo Health Designates HeartSciences’ MyoVista Insights™ as Endorsed ECG Management Platform for Network of 123 Independent Hospitals
12/22
08:02 am
hscs
HeartSciences (NASDAQ:HSCS) had its price target raised by analysts at Ascendiant Capital Markets from $9.00 to $9.20. They now have a "buy" rating on the stock.
Low
Report
HeartSciences (NASDAQ:HSCS) had its price target raised by analysts at Ascendiant Capital Markets from $9.00 to $9.20. They now have a "buy" rating on the stock.
12/15
06:47 pm
hscs
Heart Test Laboratories reports Q2 results [Seeking Alpha]
High
Report
Heart Test Laboratories reports Q2 results [Seeking Alpha]
12/15
04:15 pm
hscs
HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update
High
Report
HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update
12/15
08:30 am
hscs
HeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ Device
High
Report
HeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ Device
12/11
09:13 am
hscs
HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1 [Yahoo! Finance]
Medium
Report
HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1 [Yahoo! Finance]
12/11
08:30 am
hscs
HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1
Medium
Report
HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1